Lung cancer incidence and mortality in China, 2008

被引:63
作者
Zeng, Hongmei
Zheng, Rongshou
Zhang, Siwei
He, Jie
Chen, Wanqing [1 ,2 ]
机构
[1] Natl Off Canc Prevent & Control, Beijing 100021, Peoples R China
[2] Natl Canc Ctr, Beijing 100021, Peoples R China
关键词
cancer epidemiology; cancer screening; lung cancer;
D O I
10.1111/j.1759-7714.2012.00160.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: To provide cancer statistics to health planners, researchers, and the public, we reported the incidence and mortality data of lung cancer in 2008 in Chinese registration areas by age, sex, and geographic area. Methods: In 2011, 56 population-based cancer registries reported the lung cancer incidence and mortality data of 2008 to the Chinese National Central Cancer Registry. Forty-one registries' data met the national criteria. The crude incidence and mortality rates of lung cancer were calculated by age, gender, and area. Age-standardized rates were calculated using the Chinese and World populations. Results: The crude incidence rate for lung cancer was 54.75/100000 (73.12/100000 for male and 36.08/100000 for female; 57.96/100000 in urban and 42.80/100000 in rural). Age-standardized rates by China population (CASR) and World population (WASR) for incidence were 24.98/100000 and 34.07/100000, respectively. The crude mortality rate for lung cancer was 46.07/100000 (62.47/100000 for male and 29.39/100000 for female; 48.76/100000 in urban and 36.03/100000 in rural). The CASR and WASR for mortality were 20.09/100000 and 27.68/100000, respectively. Both for incidence and mortality, the rates for lung cancer were higher in males than in females, and in urban areas than in rural areas. The overall age-specific incidence and mortality rates showed that both rates were relatively low up to 35 years of age, but dramatically increased from such age, reaching a peak with subjects of 8084 years old. Conclusion: The burden of lung cancer remains high in China, especially for males in urban areas. Effective intervention, such as smoking control, should be enhanced in the future.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 10 条
[1]
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[2]
Evaluation on the incidence, mortality and tendency of lung cancer in China [J].
Chen, Wanqing ;
Zhang, Siwei ;
Zou, Xiaonong .
THORACIC CANCER, 2010, 1 (01) :35-40
[3]
Chen Z., 2008, 3 NATL DEATH CAUSE S
[4]
Curado M.P., 2007, IARC Scientific Publication, V160
[5]
Felay J, 2005, 42 IARC
[6]
The Decline in US Cancer Mortality in People Born since 1925 [J].
Kort, Eric J. ;
Paneth, Nigel ;
Woude, George F. Vande .
CANCER RESEARCH, 2009, 69 (16) :6500-6505
[7]
Li GL, 2009, ASIAN PAC J CANCER P, V10, P559
[8]
Parkin DM, 1994, 19 IARC
[9]
Zhang SW, 2009, B CHINESE CANC, V18, P256
[10]
Zhao P., 2011, Chinese Cancer incidence and mortality 2003-2007